EUVIMEDEUVIMED entdecken
Open Access

Loss of atrial natriuretic peptide signaling causes insulin resistance, mitochondrial dysfunction, and low endurance capacity

Deborah Carper iD, Marlène Lac iD, Marine Coue iD, Axel Labour iD, Andre Märtens iD, Jorge Alberto Ayala Banda iD, Laurène Mazeyrie, Mie Mechta, Lars Roed Ingerslev iD, Mohamed Elhadad iD, Justine Vily Petit, Claire Maslo und 29 weitere

Science Advances · 2024

DOI: 10.1126/sciadv.adl4374 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Deborah Carper und 40 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Metabolic and Cardiovascular Diseases, INSERM/Paul Sabatier University, UMR1297, Team MetaDiab, Toulouse, France. Hauptthemen laut MEDLINE: Insulin Resistance, Signal Transduction, Atrial Natriuretic Factor, Receptors, Atrial Natriuretic Factor. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes (T2D) and obesity are strongly associated with low natriuretic peptide (NP) plasma levels and a down-regulation of NP guanylyl cyclase receptor-A (GCA) in skeletal muscle and adipose tissue. However, no study has so far provided evidence for a causal link between atrial NP (ANP)/GCA deficiency and T2D pathogenesis. Here, we show that both systemic and skeletal muscle ANP/GCA deficiencies in mice promote metabolic disturbances and prediabetes. Skeletal muscle insulin resistance is further associated with altered mitochondrial function and impaired endurance running capacity. ANP/GCA-deficient mice exhibit increased proton leak and reduced content of mitochondrial oxidative phosphorylation proteins. We further show that GCA is related to several metabolic traits in T2D and positively correlates with markers of oxidative capacity in human skeletal muscle. Together, these results indicate that ANP/GCA signaling controls muscle mitochondrial integrity and oxidative capacity in vivo and plays a causal role in the development of prediabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceSignal TransductionAtrial Natriuretic FactorReceptors, Atrial Natriuretic FactorMuscle, SkeletalDiabetes Mellitus, Type 2MitochondriaAnimalsMiceHumansPhysical EnduranceMaleMice, KnockoutOxidative Phosphorylation

Substanzen

Atrial Natriuretic FactorReceptors, Atrial Natriuretic Factoratrial natriuretic factor receptor A

Autor:innen und Institutionen

  • Institute of Metabolic and Cardiovascular Diseases, INSERM/Paul Sabatier University, UMR1297, Team MetaDiab, Toulouse, France.
  • Department of Bioinformatics and Biochemistry, Braunschweig Integrated Centre of Systems Biology (BRICS), Technische Universität Braunschweig and Physikalisch-Technische Bundesanstalt, Brunswick, Germany.
  • Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
  • INSERM U1213, Nutrition, Diabète et Cerveau, Lyon, France.
  • Institut NeuroMyoGène, Université Claude Bernard Lyon 1, INSERM U1315, CNRS UMR, 5261 Lyon, France.

ORCID-Profile: Deborah Carper, Marlène Lac, Marine Coue, Axel Labour, Andre Märtens, Jorge Alberto Ayala Banda, Lars Roed Ingerslev, Mohamed Elhadad, Laurent Monbrun, Yannis Sainte-Marie, Claire Laurens, Denis R Joanisse, Charles Coudray, Emilie Montastier, Nathalie Viguerie, Annette Peters, Jerzy Adamski, Karsten Suhre, Christian Gieger, Gabi Kastenmüller, Thomas Illig, Romain Barrès, Michaela Kuhn, Dominik Pesta, Cedric Moro

Zitieren

APA

Carper, D., Lac, M., Coue, M., Labour, A., Märtens, A., Banda, J. A. A., Mazeyrie, L., Mechta, M., Ingerslev, L. R., Elhadad, M., Petit, J. V., Maslo, C., Monbrun, L., Del Carmine, P., Sainte-Marie, Y., Bourlier, V., Laurens, C., Mithieux, G., Joanisse, D. R., …, & Moro, C. (2024). Loss of atrial natriuretic peptide signaling causes insulin resistance, mitochondrial dysfunction, and low endurance capacity. Science Advances. https://doi.org/10.1126/sciadv.adl4374

Vancouver

Carper D, Lac M, Coue M, Labour A, Märtens A, Banda JAA, et al. Loss of atrial natriuretic peptide signaling causes insulin resistance, mitochondrial dysfunction, and low endurance capacity. Science Advances. 2024. doi:10.1126/sciadv.adl4374

BibTeX
@article{Carper2024,
  author = {Carper, Deborah and Lac, Marlène and Coue, Marine and Labour, Axel and Märtens, Andre and Banda, Jorge Alberto Ayala and Mazeyrie, Laurène and Mechta, Mie and Ingerslev, Lars Roed and Elhadad, Mohamed and Petit, Justine Vily and Maslo, Claire and Monbrun, Laurent and Del Carmine, Peggy and Sainte-Marie, Yannis and Bourlier, Virginie and Laurens, Claire and Mithieux, Gilles and Joanisse, Denis R and Coudray, Charles and Feillet-Coudray, Christine and Montastier, Emilie and Viguerie, Nathalie and Tavernier, Geneviève and Waldenberger, Melanie and Peters, Annette and Wang-Sattler, Rui and Adamski, Jerzy and Suhre, Karsten and Gieger, Christian and Kastenmüller, Gabi and Illig, Thomas and Lichtinghagen, Ralf and Seissler, Jochen and Mounier, Remy and Hiller, Karsten and Jordan, Jens and Barrès, Romain and Kuhn, Michaela and Pesta, Dominik and Moro, Cedric},
  title = {Loss of atrial natriuretic peptide signaling causes insulin resistance, mitochondrial dysfunction, and low endurance capacity},
  journal = {Science Advances},
  year = {2024},
  doi = {10.1126/sciadv.adl4374}
}
Kostenlos starten →